Anti-Viral Protocol

Anti-Viral Protocol

Anti-Viral Protocol

Oftentimes, a Lyme patient may not take into consideration that attending viruses, such as Epstein Barr or CMV, can be affecting the progress of their treatments. The Anti-Viral Protocol addresses just that. An Anti-metabolic agent is used as an RNA polymer and nucleotide inhibitor, possessing a high Anti-viral activity, acting as well by partial inhibition of Viral DNA synthesis. This in turn prevents Viral replication just at the lowest dose necessary to sensitize organisms for photo-exposure, from which such cyclic molecules absorbs a photon, and one of its electrons is promoted into a higher energy (elevating it into S0, a short lived electronically excited stage, followed by apoptosis, as photochemotherapy combined therapy). We prolong the anti-metabolic agent’s medium half life by applying it at 4 drops per minute and in some cases for 24 hours straight, allowing a maximum anti virus replication effect, followed by photo exposure. (Each dose, anti-metabolic agent selection and exposure time is case dependent).

Translate »